|Bid||234.50 x 4000|
|Ask||238.87 x 800|
|Day's Range||230.38 - 236.77|
|52 Week Range||35.61 - 238.42|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||208.69|
Speaking of businesses flying high right now, three Fool.com contributors think NVIDIA (NASDAQ: NVDA), Fastly (NYSE: FSLY), and Sea (NYSE: SE) are worth considering if you don't own them yet -- even after triple-digit percentage returns in 2020. Nicholas Rossolillo (NVIDIA): This top semiconductor company is no secret. Driven by its graphics processing technology (historically the realm of high-end video games), NVIDIA has been finding all sorts of new outlets for its chip designs.
Few companies in the drug-development space have offered game-changing potential for their patients quite like Vertex Pharmaceuticals (NASDAQ: VRTX). While all eyes are on COVID-19 vaccine stocks, Vertex is simply dominating the treatment landscape for cystic fibrosis (CF) -- a genetic disease characterized by thick mucus production that can obscure the lungs and pancreas. Although CF doesn't have a cure, Vertex has brought to market a number of gene-based treatments that are improving lung function and quality of life for CF patients.
In the latest trading session, Sea Limited Sponsored ADR (SE) closed at $226.05, marking a -1.57% move from the previous day.